Market Insights

Who's Got the Checkbook Now? | Ep. 707

From Mag7 Meltdown to Biotech Rotation - Where Smart Capital Is Going

7 hrs ago

Biotech’s $10B Moment | Ep. 700

Exits Are Outrunning Fund Size

Jun 12

Stalled at the Gate | Ep. 693

How Biotech’s Capital Markets Became a Traffic Jam

Jun 5

Biotech is Crowded | Ep. 686

Its not a Pipeline, Its a Pileup

May 29

Biotech's Split Screen | Ep. 680

Why Launch Wins and M&A Optimism Are Clashing With a Brutal Financing Reality

May 22

The MFN Threat | Ep. 673

How Far Will Trump Go on Drug Pricing?

May 15

Syndicate Signals | Ep. 666

Decoding Biotech’s Q1 2025 Funding Patterns

May 8

Pharma’s Topline Cliff and the Coming Biotech Buyout Wave | Ep. 659

LOEs, Valuations, Growth Projections, Catalysts

May 1

The Biotech Bottom, Bessent Backstop & Defensive Investing | Ep. 652

Why Biotech May Have Bottomed & The Underrated Role of Pharma Stocks

Apr 24

The Great Biotech Reset | Ep. 645

Down Rounds, Secondary Sales, and the Future of Startup Liquidity

Apr 17 •

Preserving Shrinking Cash Runways | Ep. 638

How Biotech Startups Are Adapting to a Tighter Funding Market

Apr 10 •

Debt > Equity? | Ep. 631

Using Debt as a Strategic Financing Tool

Apr 3 •

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts